Updated 22 March 2017

Colonoscopies could reduce cancer risk by 40%

A colonoscopy every 10 years could prevent 40% of colon cancers, according to a US study, supporting the effectiveness of the test.


Those with family history of colon cancer – the second-leading cause of cancer deaths in the US – should have more frequent screenings, the study in the New England Journal of Medicine said.

The results confirm the current recommendations for colonoscopies, offering evidence it is particularly useful in preventing cancers that originate in the proximal, or upper, part of the colon.

The study

"Our study provides strong evidence that colonoscopy is an effective technique for preventing cancers of both distal and proximal regions of the colorectum," said Shuji Ogino, a lead author from the Havard School of Public Health.

The screening is crucial in preventing proximal cancers, he explained, because another test, called sigmoidoscopy, uses a scope to examine only the lower part of the colon and "alone is insufficient for preventing proximal cancer".

Unlike sigmoidoscopy, a colonoscopy examines the entire colon, using a camera-equipped device that also has tools to remove cysts and benign tumours.

The authors analysed data from nearly 89 000 participants in two long-term studies, basing their conclusions on surveys completed every two years between 1988 and 2008.

The researchers also obtained information on any colonoscopies and sigmoidoscopies conducted. They documented 1 815 cases of colorectal cancer and 474 resulting deaths.

Findings of the study

They found that both screenings reduced the risk of developing, or dying from, colorectal cancers.

But only the more complete, colonoscopy screening reduced the risk of cancers in the upper part of the colon – though even still, its effects were less successful than for preventing lower bowel cancers.

They estimated that, if all the participants had undergone a colonoscopy, the overall risk of colorectal cancers would have been reduced by 40% – preventing 61% of lower colon cancers and just 22% of upper colon cancers.

The researchers speculated there may be molecular or biological differences between upper and lower colon cancers behind the lower success rate.


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst. For more information, visit

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules